Clinical Insights
Cost & Access
Research & Ethics
Substance Focus
Therapist Role
100

Thomson & Thomacos (2025) found that psychedelic-assisted therapy most commonly led to improvements in which of the following areas?

A. Physical health and mobility 

 B. Cognitive performance and memory 

 C. Emotional openness and self-compassion 

 D. Sleep quality and appetite regulation 

C. Emotional openness and self-compassion

100

 According to Marseille et al. (2022), which of the following is a major economic barrier to implementing psychedelic-assisted therapy in public health systems? 

A. Lack of FDA approval 

 B. High cost of psychedelic substances 

C. Time-intensive therapy sessions requiring trained professionals

 D. Limited patient interest in psychedelic treatments 

C. Time-intensive therapy sessions requiring trained professionals

100

Which of the following was a key methodological limitation noted by Thomson & Thomacos (2025) in the existing literature? 

A. Over-reliance on animal models 

B. Lack of standardized dosing protocols 

C. Excessive use of randomized controlled trials 

 D. Long-term follow-up data was too extensive 

B. Lack of standardized dosing protocols

100

Which psychedelic compound is most frequently studied in clinical trials for treatment-resistant depression? 

A. LSD 

B. MDMA 

C. Psilocybin 

D. Ketamine 

C. Psilocybin

100

How might the therapist’s role evolve in psychedelic-assisted therapy compared to traditional psychotherapy? 

A. Therapists will become passive observers 

B. Therapists will focus solely on pharmacological education 

C. Therapists will act as facilitators of altered states and integration guides 

D. Therapists will be replaced by AI systems

C. Therapists will act as facilitators of altered states and integration guides

200

Reiff et al. (2020) identified which two psychiatric conditions as showing the most promise for psychedelic-assisted psychotherapy? 

A. Bipolar disorder and schizophrenia 

 B. PTSD and treatment-resistant depression 

 C. ADHD and generalized anxiety disorder 

 D. Borderline personality disorder and OCD 

B. PTSD and treatment-resistant depression

200

What solution does Marseille et al. (2022) propose to improve the cost-effectiveness of psychedelic-assisted therapy? 

A. Reducing the dosage of psychedelics 

 B. Using virtual reality to simulate psychedelic effects 

 C. Implementing group therapy and digital support tools 

 D. Eliminating the need for therapists during sessions 

 C. Implementing group therapy and digital support tools

200

Reiff et al. (2020) recommend which of the following safety protocols for psychedelic-assisted therapy? 

A. Mandatory hospitalization during sessions 

 B. Use of antipsychotic medication as a precaution 

C. Pre-screening for psychiatric risk and post-session integration therapy

 D. Avoidance of any emotional expression during sessions 

C. Pre-screening for psychiatric risk and post-session integration therapy

200

According to Zamaria et al. (2025), what is a potential risk of focusing too heavily on the psychedelic substance rather than the therapeutic context? 

A. Increased physical dependency 

 B. Reduced effectiveness of the drug 

 C. Misinterpretation of the experience and psychological harm 

 D. Legal consequences for therapists 

 C. Misinterpretation of the experience and psychological harm

200

Across all four articles, which theme is consistently emphasized regarding the future of psychedelic-assisted therapy? 

A. The need for more potent psychedelic compounds 

B. The importance of therapist training and integration support 

C. The elimination of psychotherapy from the process 

D. The commercialization of psychedelic retreats 

B. The importance of therapist training and integration support

300

What is a common outcome reported across studies on psychedelic-assisted therapy? 

 A. Increased risk of addiction 

 B. Long-term cognitive decline 

 C. Enhanced psychological flexibility and reduced symptom severity 

 D. Decreased interest in traditional psychotherapy 

C. Enhanced psychological flexibility and reduced symptom severity

300

What role do digital support tools play in the model proposed by Marseille et al. (2022)? 

 A. They replace therapists entirely 

 B. They provide post-session integration and monitoring

 C. They simulate psychedelic experiences 

 D. They are used to administer psychedelics remotely 

B. They provide post-session integration and monitoring

300

What ethical concern is commonly raised in the context of psychedelic-assisted therapy research? 

 A. Overuse of placebo controls 

 B. Informed consent during altered states of consciousness

 C. Lack of diversity in psychedelic compounds 

 D. Excessive government funding 

B. Informed consent during altered states of consciousness

300

Zamaria et al. (2025) argue that psychotherapy is essential in psychedelic-assisted therapy because: 

A. It reduces the cost of treatment 

B. It ensures legal compliance 

C. It helps integrate the psychedelic experience into lasting psychological change 

D. It prevents physical side effects 

C. It helps integrate the psychedelic experience into lasting psychological change

300

According to Reiff et al. (2020), what is a critical factor in determining patient eligibility for psychedelic-assisted therapy? 

 A. Age over 65 

 B. History of substance use 

 C. Psychiatric stability and absence of psychosis 

 D. Prior experience with meditation 

 C. Psychiatric stability and absence of psychosis